Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment - interview with Federico Cappuzzo episode artwork

EPISODE · Apr 14, 2022 · 12 MIN

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment - interview with Federico Cappuzzo

from Medical Digest & Congress Report · host Medical Congress News

Professor Federico Cappuzzo gave us an update on the emerging data on the field of lung cancer. There are very important news that were presented during the ESMO, ELCC and EACR. These data are clearly changing the standard of care of patients with early stage Non-Small-Cell Lung Cancer. In this field we have data from two very important trial: the IMpower010 and the KEYNOTE-09. Video: https://congressreport.eu/scientific-contents/standalonecontent:paradigm-shift-early-nsclc-role-icis-adjuvant-treatment

Episode metadata supplied by the publisher feed · Published Apr 14, 2022

Embed this episode

Ready to play

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment - interview with Federico Cappuzzo

0:00 12:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 12 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 14, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!